STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3708 by analyst upside · 2026-08-14
MTD
Mettler-Toledo International, I
Healthcare · Market Cap $29B · P/E 32.3x
ANALYST PRICE TARGET
+2.7%
implied upside to consensus target
Current Price $1430.76
Consensus Target $1468.91
Bull Target $1600.0
Bear Target $1200.0
Analysts Covering 11
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
4
Hold
6
Sell
0
52-Week Low $1023.05
52-Week High $1525.17
YTD Return +1.4%
FUNDAMENTALS
Market Cap $29B
P/E Ratio (TTM) 32.3x
Forward P/E 27.7x
EPS (TTM) $44.31
PEG Ratio 2.94
Dividend Yield N/A
Revenue (TTM) $4.1B
Profit Margin 21.9%
52-WEEK RANGE
52-Week Low $1023.05
52-Week High $1525.17
Current Price $1430.76
Bear Target $1200.0
Bull Target $1600.0
● Now $1430.76 ● Target $1468.91
TRADING DATA
Avg Volume 203K
YTD Return +1.4%
Analyst Count 11
Consensus Buy
Upside to Target +2.7%
Last Updated 2026-08-14

ANALYST SUMMARY

Mettler-Toledo International, I (MTD) is currently trading at $1430.76 with a Wall Street consensus price target of $1468.91, implying potential upside of 2.7% over the next 12 months. 11 analysts currently cover MTD, with a consensus rating of Buy - 45% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1600.0, while the most cautious has a target of $1200.0.

MTD operates in the Healthcare sector with a market capitalisation of $29B. The stock is up 1.4% year-to-date and is currently trading near the upper end of its 52-week range of $1023.05 – $1525.17.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MTD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Stifel - Reiterated
Buy → Buy 2026-05-18 Building track record
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-05-12 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-05-11 43% win rate (7 calls)
Baird - Reiterated
Neutral → Neutral 2026-05-11 Building track record
Citigroup - Reiterated
Buy → Buy 2026-05-08 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-04-14 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-04-06 Building track record
Jefferies ↑ Upgrade
Hold → Buy 2026-03-20 50% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
50
out of 100
Coverage depth
19/30
Consensus clarity
24/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →